Concepedia

Jeff Hutchins

JH

25

Publications

1.5K

Citations

21

H-Index

1998

Active since

Affiliations

Research Triangle Park Foundation(Current)

Senex Biotechnology (United States)

Avid Bioservices (United States)

Cardiff University

GlaxoSmithKline (United States)

Jeff Hutchins is an author at Research Triangle Park Foundation specializing in medicine, immunology, and pharmacology.

Top concepts

Publications per year

1998–2022

25

Publications

25

Inhibition of colony-stimulating-factor-1 signaling<i>in vivo</i>with the orally bioavailable cFMS kinase inhibitor GW2580

James G. Conway, Brad McDonald, Janet H. Parham et al. · Proceedings of the National Academy of Sciences · 2005 · 252 citations · Full text

Characterization of a Protective Monoclonal AntibodyRecognizing <i>Staphylococcus aureus</i> MSCRAMM ProteinClumping FactorA

Andrea Hall, Paul Domanski, Pratiksha Patel et al. · Infection and Immunity · 2003 · 144 citations · Full text

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression

Canan Kasikara, Sushil Kumar, Stanley Kimani et al. · Molecular Cancer Research · 2017 · 122 citations · Full text

Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus

Christopher McGuigan, Karolina Madela, Mohamed Aljarah et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 99 citations

, , +9

INX-08189, a Phosphoramidate Prodrug of 6-<i>O</i>-Methyl-2′-<i>C</i>-Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic and Pharmacodynamic Properties

John Vernachio, Blair Bleiman, K. Dawn Bryant et al. · Antimicrobial Agents and Chemotherapy · 2011 · 84 citations · Full text

Rows per page

1–5 of 25